Have a personal or library account? Click to login

Chemometrically assissted optimization and validation of RP-HPLC method for the analysis of itraconazole and its impurities

Open Access
|Jul 2013

References

  1. 1. A. M. Siouffi and R. Phan-Tan-Luu, Optimization methods in chromatography and capillary electrophoresis, J. Chromatogr. A 892 (2000) 75-106; DOI: 10.1016/S0021-9673(00)00247-8.10.1016/S0021-9673(00)00247-8
  2. 2. A. Malenović, Y. Dotsikas, M. Mašković, B. Jančić Stojanović, D. Ivanović and M. Medenica, Desirability-based optimization and its sensitivity analysis for the perindopril and its impurities analysis in a microemulsion LC system, Microchem. J. 99 (2011) 454-460; DOI: 10.1016/j.microc. 2011.06.022.
  3. 3. M. A. Bezerra, R. E. Santelli, E. P. Oliveira, L. S. Villar and L. A. Escaleira, Response surface methodology (RSM) as a tool for optimization in analytical chemistry, Talanta 76 (2008) 965-977; DOI: 10.1016/j.talanta.2008.05.019.10.1016/j.talanta.2008.05.019
  4. 4. S. L. C. Ferreira, W. N. L. Dos Santos, C. M. Quintella, B. B. Neto and J. M. Bosque-Sendra, Doehlert matrix: A chemometric tool for analytical chemistry-Review, Talanta 63 (2004) 1061-1067; DOI: 10.1016/j.talanta.2004.01.015.10.1016/j.talanta.2004.01.015
  5. 5. Y. Vander Heyden and D. L. Massart, Review of the Use of Robustness and Ruggedness in AnalyticalChemistry, in Robustness of Analytical Chemical Methods and Pharmaceutical Technological Products (Eds. M. W. B. Hendriks, J. H. De Boer and A. K. Smilde), Elsevier, Amsterdam 1996.10.1016/S0922-3487(96)80016-5
  6. 6. Y. VanderHeyden, A. Nijhuis, J. Smeyers-Verbeke, B. G. M. Vandeginste and D. L. Massart, Guidance for robustness/ruggedness tests in method validation, J. Pharm. Biomed. Anal. 24 (2001) 723-753; DOI: 10.1016/S0731-7085(00)00529-X.10.1016/S0731-7085(00)00529-X
  7. 7. M. Mašković, B. Jančić-Stojanović, A. Malenović, D. Ivanović and M. Medenica, Assessment of liquid chromatographic method robustness by use of Plackett-Burman design, Acta Chromatogr. 22 (2010) 281-296; DOI: 10.1556/AChrom.22.2010.2.10.10.1556/AChrom.22.2010.2.10
  8. 8. T. Rakić, A. Malenović, B. Jančić-Stojanović, D. Ivanović and M. Medenica, Avoiding the false negative results in LC method robustness testing by modifications of the algorithm of Dong and dummy factor effects approach, Chromatographia 75 (2012) 397-401; DOI: 10.1007/s10337-012-2196-6.10.1007/s10337-012-2196-6
  9. 9. European Pharmacopeia, 7th ed., Council of Europe, Strasbourg 2011, pp. 2297-2299.
  10. 10. M. Dumarey, R. Sneyers, W. Janssens, I. Somers and Y. Vander Heyden, Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase, Anal. Chim. Acta 656 (2009) 85-92; DOI: 10.1016/j.aca.2009.10.013.10.1016/j.aca.2009.10.013
  11. 11. D. Compas, D. J. Touw and P. N. F. C. de Goede, Rapid method for the analysis of itraconazole and hydroxyitraconazole in serum by high-performance liquid chromatography, J. Chromatogr. B 687 (1996) 453-456; DOI: 10.1016/S0378-4347(96)00245-9.10.1016/S0378-4347(96)00245-9
  12. 12. C. H. W. Koks, R. W. Sparidans, G. Lucassen, K. M. L. Crommentuyn and J. H. Beijnen, Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patients, J. Chromatogr. B 767 (2002) 103-110; DOI: 10.1016/S0378-4347(01)00550-3.10.1016/S0378-4347(01)00550-3
  13. 13. V. Srivatsan, A. K. Dasgupta, P. Kale, R. R. Datla, D. Soni, M. Patel, R. Patel and C. Mavadhiya, Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high- -performance liquid chromatography, J. Chromatogr. A 1031 (2004) 307-313; DOI: 10.1016/j.chroma. 2003.11.061.
  14. 14. T. Uno, M. Shimizu, K. Sugawara and T. Tateishi, Sensitive determination of itraconazole and its active metabolite in human plasma by column-switching high-performance liquid chromatography with ultraviolet detection, Ther. Drug Monit. 28 (2006) 526-531; DOI: 10.1097/00007691-200608000-00007.10.1097/00007691-200608000-00007
  15. 15. P. Kubalec and E. Brandšteterová, Column-switching chromatographic determination of itraconazole and its metabolite hydroxy-itraconazole in human serum, Pharmazie 56 (2001) 397-400.
  16. 16. W. C. Young, D. Nam, H. K. Kyoung, W. H. Kyung, H. H. In, K. C. Byung, M. Yoon and J. Lee, High-performance liquid chromatographic-tandem mass spectrometric determination of itraconazole in human plasma for bioavailability and bioequivalence studies, Bull. Korean Chem. Soc.27 (2006) 291-294; DOI: 10.5012/bkcs.2006.27.2.291.10.5012/bkcs.2006.27.2.291
  17. 17. L. Bai, M. M. Li, C. J. Zhao and T. T. Ma, Determination of itraconazole in human plasma by HPLC and studies of bioequivalence, Chinese Pharmaceut. J. 43 (2008) 1272-1274.
  18. 18. J.W.Wong, U. R. Nisar and K. H. Yuen, Liquid chromatographic method for the determination of plasma itraconazole and its hydroxy metabolite in pharmacokinetic/bioavailability studies, J. Chromatogr. B 798 (2003) 355-360; DOI: 10.1016/j.jchromb.2003.09.059.10.1016/j.jchromb.2003.09.059
  19. 19. L. Baietto, A. D’Avolio, G. Ventimiglia, F. G. De Rosa, M. Siccardi, M. Simiele, M. Sciandra and G. Di Perri, Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma, Antimicrob. Agents Chemother. 54 (2010) 3408-3413; DOI: 10.1128/AAC.01807-09. 10.1128/AAC.01807-09
  20. 20. W. Chen, B. Gu, H. Wang, J. Pan,W. Lu and H. Hou. Development and evaluation of novel itraconazole- loaded intravenous nanoparticles, Int. J. Pharm. 362 (2008) 133-140; DOI: 10.1016/j.ijpharm. 2008.05.039.
  21. 21. L. Gagliardi, D. De Orsi, P. Chimenti, R. Porra and D. Tonelli, HPLC determiantion of imidazole antimycotics in antidandruff cosmetic products, Anal. Sci. 19 (2003) 11951197; DOI: 10.2116/analsci. 19.1195.
  22. 22. S. L. C. Ferreira, R. E. Bruns, E. G. P. da Silva, W. N. L. dos Santos, C. M. Quintella, J. M. Davis, J. B. de Andrade, M. C. Breitkreitz, I. C. S. F. Jardim and B. B. Neto, Statistical designs and response surface techniques for the optimization of chromatographic systems, J. Chromatogr. A 1158 (2007) 2-14; DOI: 10.1016/j.chroma.2007.03.051.10.1016/j.chroma.2007.03.051
  23. 23. R. L. Mason, R. F. Gunst and J. L. Hess, Statistical Design and Analysis of Experiments With Applicationto Engineering and Science, 2nd ed., Hoboken, New York 2003.10.1002/0471458503
  24. 24. G. C. Carle, Determination of chromatographic resolution for peaks of vast concentration differences, Anal. Chem. 44 (1972) 1905-1906.10.1021/ac60319a030
  25. 25. R. E. Kaiser, Gas Chromatographie, Portig, Leipzig 1960, p. 33.10.1007/978-1-4684-8291-1_2
  26. 26. F. Dong, On the identification of active contrasts in unreplicated fractional factorials, Stat. Sinica3 (1993) 209-217.
  27. 27. J. B. Crowther, Validation of Pharmaceutical Test Methods, in Handbook of Modern PharmaceuticalAnalysis (Eds. S. Ahuja and S. Scypinski), Academic Press, New York 2001, pp. 415-443. 10.1016/S0149-6395(01)80014-3
DOI: https://doi.org/10.2478/acph-2013-0015 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 159 - 173
Published on: Jul 10, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:

© 2013 Irena Kasagić, Anđelija Malenović, Marko Jovanović, Tijana Rakić, Biljana Jančić Stojanović, Darko Ivanović, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.